R. Wu's Profile

Role	Title	Level	Year	L/R
🐜	Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus 16 auth. A. Doria, Y. Shoenfeld, R. Wu, P. Gambari, M. Puato, A. Ghirardello, B. Gilburd, S. Corbanese, M. Patnaik, S. Zampieri, ... J. Peter, E. Favaretto, L. Iaccarino, Y. Sherer, S. Todesco, P. Pauletto	8	2003	8 🐜
🐬	Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases Yuan Jin, Min S Xie, C. Yang, R. Wu, Y-B Zhou, X.-M. Li	3	2021	3 🐬
🐜	[Correlation between the changes of innate lymphoid cells in peripheral blood of systemic lupus erythematosus and its clinical significance]. 9 auth. H. Chu, X. Fang, Z. Tan, X. Zhen, R. Wu, X. Li, ... G. Wang, Y. P. Wang, X. M. Li	1	2019	1 🐜
🐬	POS0015 BULLOUS SYSTEMIC LUPUS ERYTHEMATOSUS SUCCESSFULLY TREATED WITH MYCOPHENOLATE MOFETIL COMBINED WITH GLUCOCORTICOID: A CASE REPORT H. Du, J. Hu, J. Su, T. Wu, R. Wu, J. Zhu	0	2022	0 🐬
🐜	AB0049B CHANGES OF INNATE LYMPHOID CELLS IN PERIPHERAL BLOOD OF PATIENTS WITH PRIMARY SJöGREN’S SYNDROME AND ITS CORRELATIONS WITH CLINICAL MARKERS 9 auth. H. Chu, Z. Tan, X. Fang, R. Wu, Ke Wang, Li Xiangpei, ... Guo-sheng Wang, Yi-ping Wang, Xiaomei Li	0	2019	0 🐜
🐜	FRI0593 CORRELATION BETWEEN DISEASE ACTIVITY AND MENTAL HEALTH OF AS PATIENTS: A CROSS-SECTION STUDY WITH SELF-ASSESSMENTS BASED ON SMART SYSTEM OF DISEASE MANAGEMENT (SSDM) MOBILE TOOLS 20 auth. Y. Wang, H. Wei, R. Wu, Jian Wu, S. Zhang, Q. Li, Y. Li, Y. Zhao, Q. Shu, L. Kang, ... B. Wu, Ling Qin, F. Jiang, Yao Sun, H. Yang, Jing Zhang, H. Xiao, Y. Jia, F. Xiao, L. Sun	0	2020	0 🐜
🐬	AB1140 ABNORMAL RIGHT VENTRICLE RESERVE FOLLOWING EXERCISE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES J. Zhang, T. Wu, R. Wu, J. Zhu	0	2020	0 🐬
🐬	FRI0368 GOUT flare prevention with rilonacept in patients with TOPHI and/or polyarticular disease who initiate uric acid-lowering therapy R. Evans, H. Schumacher, R. Wu, C. Barton, R. Terkeltaub	0	2013	0 🐬